Azodyes as markers for tumor hypoxia imaging and therapy: An up-to-date review

Rashmi Kumari, Dhanya Sunil, Raghumani S. Ningthoujam, NV Anil Kumar

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Tumor hypoxia is the low tissue oxygen levels seen characteristically in rapidly proliferating and expanding neoplasms. It affects both malignant tumor cells and its microenvironment, resulting in dysfunctional neovascularization. This leads to epithelial-to-mesenchymal transition phenotype, facilitating tumor progression through cell mobility, invasion, and metastasis. The hypoxic condition in solid tumors is thus an indicator of the process of cancer progression towards an aggressive malignant phenotype with an enhanced possibility of metastasis and resistance to treatment. Advancements in the detection of tumor hypoxia and its utilization as a treatment modality in solid tumors are highly imperative. The use of fluorescent probes is an evolving field for detecting hypoxic tumors in biological systems. The present review is an attempt to provide a contextual knowledge on the prominent role of tumor hypoxia in cancer progression and dissemination. The use of azodyes in detecting tumor hypoxia aiding in cancer diagnosis through fluorescence off-on imaging and azodye-based hypoxia selective pro-drugs for assisting cancer therapy are presented. The limitations of fluorescence based hypoxia imaging and further investigations desired for clinical usage of azodye based hypoxic probes for fluorescence imaging are also considered.

Original languageEnglish
Pages (from-to)91-104
Number of pages14
JournalChemico-Biological Interactions
Volume307
DOIs
Publication statusPublished - 01-07-2019

Fingerprint

Tumor Biomarkers
Tumors
Imaging techniques
Neoplasms
Therapeutics
Fluorescence
Optical Imaging
Tumor Hypoxia
Neoplasm Metastasis
Phenotype
Cellular Microenvironment
Prodrugs
Epithelial-Mesenchymal Transition
Biological systems
Fluorescent Dyes
Cells
Tissue
Oxygen

All Science Journal Classification (ASJC) codes

  • Toxicology

Cite this

@article{876735ecd9a248f2957dcfc9343c839a,
title = "Azodyes as markers for tumor hypoxia imaging and therapy: An up-to-date review",
abstract = "Tumor hypoxia is the low tissue oxygen levels seen characteristically in rapidly proliferating and expanding neoplasms. It affects both malignant tumor cells and its microenvironment, resulting in dysfunctional neovascularization. This leads to epithelial-to-mesenchymal transition phenotype, facilitating tumor progression through cell mobility, invasion, and metastasis. The hypoxic condition in solid tumors is thus an indicator of the process of cancer progression towards an aggressive malignant phenotype with an enhanced possibility of metastasis and resistance to treatment. Advancements in the detection of tumor hypoxia and its utilization as a treatment modality in solid tumors are highly imperative. The use of fluorescent probes is an evolving field for detecting hypoxic tumors in biological systems. The present review is an attempt to provide a contextual knowledge on the prominent role of tumor hypoxia in cancer progression and dissemination. The use of azodyes in detecting tumor hypoxia aiding in cancer diagnosis through fluorescence off-on imaging and azodye-based hypoxia selective pro-drugs for assisting cancer therapy are presented. The limitations of fluorescence based hypoxia imaging and further investigations desired for clinical usage of azodye based hypoxic probes for fluorescence imaging are also considered.",
author = "Rashmi Kumari and Dhanya Sunil and Ningthoujam, {Raghumani S.} and Kumar, {NV Anil}",
year = "2019",
month = "7",
day = "1",
doi = "10.1016/j.cbi.2019.04.034",
language = "English",
volume = "307",
pages = "91--104",
journal = "Chemico-Biological Interactions",
issn = "0009-2797",
publisher = "Elsevier Ireland Ltd",

}

Azodyes as markers for tumor hypoxia imaging and therapy : An up-to-date review. / Kumari, Rashmi; Sunil, Dhanya; Ningthoujam, Raghumani S.; Kumar, NV Anil.

In: Chemico-Biological Interactions, Vol. 307, 01.07.2019, p. 91-104.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Azodyes as markers for tumor hypoxia imaging and therapy

T2 - An up-to-date review

AU - Kumari, Rashmi

AU - Sunil, Dhanya

AU - Ningthoujam, Raghumani S.

AU - Kumar, NV Anil

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Tumor hypoxia is the low tissue oxygen levels seen characteristically in rapidly proliferating and expanding neoplasms. It affects both malignant tumor cells and its microenvironment, resulting in dysfunctional neovascularization. This leads to epithelial-to-mesenchymal transition phenotype, facilitating tumor progression through cell mobility, invasion, and metastasis. The hypoxic condition in solid tumors is thus an indicator of the process of cancer progression towards an aggressive malignant phenotype with an enhanced possibility of metastasis and resistance to treatment. Advancements in the detection of tumor hypoxia and its utilization as a treatment modality in solid tumors are highly imperative. The use of fluorescent probes is an evolving field for detecting hypoxic tumors in biological systems. The present review is an attempt to provide a contextual knowledge on the prominent role of tumor hypoxia in cancer progression and dissemination. The use of azodyes in detecting tumor hypoxia aiding in cancer diagnosis through fluorescence off-on imaging and azodye-based hypoxia selective pro-drugs for assisting cancer therapy are presented. The limitations of fluorescence based hypoxia imaging and further investigations desired for clinical usage of azodye based hypoxic probes for fluorescence imaging are also considered.

AB - Tumor hypoxia is the low tissue oxygen levels seen characteristically in rapidly proliferating and expanding neoplasms. It affects both malignant tumor cells and its microenvironment, resulting in dysfunctional neovascularization. This leads to epithelial-to-mesenchymal transition phenotype, facilitating tumor progression through cell mobility, invasion, and metastasis. The hypoxic condition in solid tumors is thus an indicator of the process of cancer progression towards an aggressive malignant phenotype with an enhanced possibility of metastasis and resistance to treatment. Advancements in the detection of tumor hypoxia and its utilization as a treatment modality in solid tumors are highly imperative. The use of fluorescent probes is an evolving field for detecting hypoxic tumors in biological systems. The present review is an attempt to provide a contextual knowledge on the prominent role of tumor hypoxia in cancer progression and dissemination. The use of azodyes in detecting tumor hypoxia aiding in cancer diagnosis through fluorescence off-on imaging and azodye-based hypoxia selective pro-drugs for assisting cancer therapy are presented. The limitations of fluorescence based hypoxia imaging and further investigations desired for clinical usage of azodye based hypoxic probes for fluorescence imaging are also considered.

UR - http://www.scopus.com/inward/record.url?scp=85065125607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065125607&partnerID=8YFLogxK

U2 - 10.1016/j.cbi.2019.04.034

DO - 10.1016/j.cbi.2019.04.034

M3 - Review article

C2 - 31047917

AN - SCOPUS:85065125607

VL - 307

SP - 91

EP - 104

JO - Chemico-Biological Interactions

JF - Chemico-Biological Interactions

SN - 0009-2797

ER -